Navigation Links
Describe your invention, or your biotech patent may be worthless

The U.S. Supreme Court made a patent-law decision on Monday that could have multibillion-dollar ramifications for patent holders in the biotechnology sector.

The court denied an appeal in Univ. of Rochester v. G.D. Searle & Co. This effectively solidifies the decision that was made by the U.S. Court of Appeals for the Federal Circuit, which invalidate......

Full article >>> ned to be significant in the production and discovery of non-steroidal and anti-inflammatory drugs.

The University of Rochester ultimately received a patent (6,048,850) which covered methods for selectively inhibiting PGHS-2 activity in a human host, comprising administering a nonsteroidal compound that selectively inhibits activity of the PGHS-2 gene product to a human host in need of su......

Full article >>> med invention.

In the case of Noelle v. Lederman, the Federal Circuit decided that a patent for an antibody need not provide a written description of the antibody. However, provided that an application discloses a fully characterized antigen, the application may properly claim an antibody by its binding affinity to that described antigen. At first glance, this may appear to contra......

Full article >>> ication that fulfills the statutory requirements. An inventor may add additional description to the application, but it must then be filed as a separate child application. The problem with this procedure is that the new matter added would have a priority date of the child application and not of the parent.

For biotechnology related inventions a matter of days can translate into considerab......

Full article >>> those of the author, & do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Jonathan Fritz 12/01/04


Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Getting noticed in Genetown: Wisconsin biotech on display
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Wisconsin biotech firm receives $107K NIH grant
6. Manufacturing partnership will move into biotech and biomedical spaces
7. Wisconsin wont get Georgia biotech without a fight
8. The 10 biggest events shaping biotech in 2006
9. NimbleGen partners with UK biotech firm
10. 2006: A great biotech financing year, unless you were going public!
11. Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... ... 2017 , ... The University of Connecticut, in partnership with ... startups through the UConn Innovation Fund. The $1.5 million UConn Innovation Fund was ... , The UConn Innovation Fund provides investments of up to $100,000 to companies ...
(Date:4/21/2017)... ... April 21, 2017 , ... Frederick Innovative Technology Center, Inc. ... bio and technology start-ups, is hosting “Celebration Friday” (a festive gathering highlighting client ... with libations and networking at 3:30 p.m. at FITCI’s 4539 Metropolitan Court location, ...
(Date:4/20/2017)... Netherlands (PRWEB) , ... April 20, 2017 , ... ... Technology today announced their strategic partnership to offer a full spectrum of ... authentication, a comprehensive suite of biometric products and the ground-breaking proactive cybersecurity services ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):